Docket Management
Docket: 03D-0061 - Draft Guid. for Indtry: Comparability Protocols-Chemistry, Manufacturing & Controls Information
Comment Number: EC -1

Accepted - Volume 1

Comment Record
Commentor Dr. Barratt Easter Date/Time 2003-02-21 07:57:02
Organization Fine Chemicals Corporation
Category Company

Comments for FDA General
1. General Comments Would it not be appropriate to mention BACPAC I at line 142?

EC -1